Summit Therapeutics SMMT Grant — Grant income
Discontinued — last reported Q3 '20
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RevenueNotFromContractWithCustomer.
The official record: Summit Therapeutics’s 10-Q, filed November 16, 2020, on SEC EDGAR. View the filing →
Questions, answered.
- What does grant — grant income mean?
- Revenue earned from external research grants and government funding to support drug development activities.
- How do you interpret grant — grant income?
- An increase suggests successful procurement of non-dilutive capital and external validation of the research pipeline, while a decrease may indicate a reduction in external funding support or the completion of specific grant-funded projects.
- How does grant — grant income compare across companies?
- Common among early-stage biopharmaceutical companies, where grant income is often compared against total R&D expenses to assess the degree of external funding support for the clinical pipeline.